Stay updated with breaking news from Janet Qi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - May 23, 2024) - PurMinds NeuroPharma ("PurMinds" or the "Company"), a clinical-stage neuroscience company focused on advancing a robust pipeline
To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from...
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.
Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - December 14, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development pipeline of small molecules, psychedelic compounds and other modalities, is pleased to announce that its management team, including Chief Executive Officer Janet Qi and Chief Scientific Officer Dr. Alan Kozikowski, will be att
NEW YORK, Jan. 18, 2022 -- via InvestorWire -- Microdose Psychedelic Insights, the leading guide to the business of psychedelics will be hosting the upcoming Psychedelic Capital: January 2022...